New painkiller aims to cut opioid use after knee replacement
NCT ID NCT07430085
First seen Feb 28, 2026 · Last updated May 21, 2026 · Updated 11 times
Summary
This study looks at whether a long-acting painkiller (bupivacaine-meloxicam) can reduce pain and the need for opioid painkillers after robot-assisted total knee replacement. About 150 adults aged 18 to 89 with knee osteoarthritis will take part. Researchers will measure pain levels and how much pain medication patients use in the first 72 hours after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS (OA) OF THE KNEE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.